Catalyst Wire Dossier Catalyst Wire Dossier

Ceftriaxone Sodium and Sulbactam Sodium for Injection

ceftriaxone-sulbactam · Xiangbei Welman Pharmaceutical Co., Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ceftriaxone Sodium and Sulbactam Sodium for Injection, covering 2019-08-28 to 2019-08-28. Get the full timeline:

Most recent: Clinical Trial Update: PHase IV Clinical Trial of Ceftriaxone Sodium and Sulbactam Sodium for Injection (CRO-SBT) [Phase 4]

See pricing